top headlines
Poolbeg Pharma has secured a South African patent covering the [...]
Lonza will expand its highly potent active pharmaceutical ingredient manufacturing [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Grifols has dosed the first participant in a Phase 3 [...]
Genoskin is expanding its US operations with a new laboratory [...]
ten23 health has obtained Good Manufacturing Practice (GMP) licences from [...]
Resalis Therapeutics has dosed the first participant in a Phase [...]
Hemab Therapeutics has highlighted new clinical and preclinical data across [...]
Elixirgen Therapeutics has signed an option agreement with Nippon Shinyaku [...]
